| Literature DB >> 34476408 |
Laura Poillet-Perez1, Daniel W Sharp1, Yang Yang1, Saurabh V Laddha1, Maria Ibrahim1, Praveen K Bommareddy1,2, Zhixian Sherrie Hu1, Joshua Vieth1, Michael Haas3, Marcus W Bosenberg4, Joshua D Rabinowitz1,5, Jian Cao1,6, Jun-Lin Guan3, Shridar Ganesan1,6, Chang S Chan1,6, Janice M Mehnert1,6, Edmund C Lattime1,7, Eileen White8,9.
Abstract
Macroautophagy (hereafter autophagy) degrades and recycles intracellular components to sustain metabolism and survival during starvation. Host autophagy promotes tumor growth by providing essential tumor nutrients. Autophagy also regulates immune cell homeostasis and function and suppresses inflammation. Although host autophagy does not promote a T-cell anti-tumor immune response in tumors with low tumor mutational burden (TMB), whether this was the case in tumors with high TMB was not known. Here we show that autophagy, especially in the liver, promotes tumor immune tolerance by enabling regulatory T-cell function and limiting stimulator of interferon genes, T-cell response and interferon-γ, which enables growth of high-TMB tumors. We have designated this as hepatic autophagy immune tolerance. Autophagy thereby promotes tumor growth through both metabolic and immune mechanisms depending on mutational load and autophagy inhibition is an effective means to promote an antitumor T-cell response in high-TMB tumors.Entities:
Mesh:
Year: 2020 PMID: 34476408 PMCID: PMC8409526 DOI: 10.1038/s43018-020-00110-7
Source DB: PubMed Journal: Nat Cancer ISSN: 2662-1347